• News & Events
  • Resources
  • Careers
  • Investors
Aptar Logo
  • Products
  • business areas
  • Services
  • ESG
  • About Aptar
Pharmaceutical, Publications

Aptar Pharma Talks Targeted Drug Delivery to the Upper Airways

9 Sep 2021

The nose and upper respiratory system function as a path for air to enter the body while contributing to olfactory function, conditioning the breathed-in air and removing debris. Serving as a primary contact point with the environment, they can be a route for the entry of contaminants or disease as well as a site for heal­ing and protection using the latest targeted delivery technologies.

By Dr. Degenhard Marx, Dr. Fotos Stylianou, Dr. Stavros Kassinos
$resourceAuthor.title, $resourceAuthor.title, $resourceAuthor.title
Share
DDD_Sept2021.jpg

Aptar Pharma’s novel PureHale® ready-to-use nebulizer-like technology was specifically developed to target the upper respiratory tract while minimizing deposition in the lower airways. PureHale provides a modern drug delivery technology option for the delivery of a fine mist for a variety of solutions to only the upper respiratory tract without significant deposition in the lungs and lower airways.